GXI logo

Gerresheimer AG Stock Price

XTRA:GXI Community·€884.9m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 25 Fair Values set on narratives written by author

GXI Share Price Performance

€25.62
-50.18 (-66.20%)
€34.62
Fair Value
€25.62
-50.18 (-66.20%)
26.0% undervalued intrinsic discount
€34.62
Fair Value
Price €25.62
AnalystConsensusTarget €34.62
AnalystLowTarget €47.50
AnalystHighTarget €100.00

GXI Community Narratives

AnalystConsensusTarget·
Fair Value €34.62 26.0% undervalued intrinsic discount

Ongoing Uncertainties And Downgrades Will Shape Efficiency Efforts Ahead

0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
AnalystLowTarget·
Fair Value €47.5 46.1% undervalued intrinsic discount

Rising Production Costs And Regulatory Burdens Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystHighTarget·
Fair Value €97.07 73.6% undervalued intrinsic discount

Secular Trends Will Drive Premium Drug Delivery Packaging Adoption

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
€34.62
26.0% undervalued intrinsic discount
Revenue
6.1% p.a.
Profit Margin
4.39%
Future PE
13.28x
Price in 2028
€45.34

Trending Discussion

Updated Narratives

GXI logo

GXI: Long-Term Sector Demand Will Support Confidence After Recent Leadership Change

Fair Value: €34.62 26.0% undervalued intrinsic discount
11 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GXI logo

Rising Production Costs And Regulatory Burdens Will Erode Margins

Fair Value: €47.5 46.1% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GXI logo

Secular Trends Will Drive Premium Drug Delivery Packaging Adoption

Fair Value: €97.07 73.6% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Slight risk and fair value.

4 Risks
2 Rewards

Gerresheimer AG Key Details

€2.3b

Revenue

€1.6b

Cost of Revenue

€605.2m

Gross Profit

€581.8m

Other Expenses

€23.4m

Earnings

Last Reported Earnings
Aug 31, 2025
Next Reporting Earnings
Feb 26, 2026
0.68
26.89%
1.04%
155.5%
View Full Analysis

About GXI

Founded
1864
Employees
13535
CEO
Uwe Röehrhoff
WebsiteView website
www.gerresheimer.com

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. It serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Recent GXI News & Updates

Recent updates

No updates